Cortagen 20mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Cortagen supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF-CORTA20-B241

Key analytical results include:

• Assay Content: 20.4 mg
• Identification – Retention Time: 0.983
• Identification – Spectrum: 994
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Cortagen is a synthetic peptide research compound frequently studied in laboratory environments focused on neurobiological signalling and peptide-mediated cellular regulation.

The compound belongs to a class of short regulatory peptides investigated in experimental models exploring neuronal signalling pathways and molecular regulatory processes within the central nervous system.

This preparation contains 20 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide sequence and stable analytical profile, Cortagen is frequently referenced in experimental neurobiological research models investigating peptide signalling mechanisms.

Compound Overview

Cortagen is a short-chain synthetic peptide originally investigated in biochemical research exploring regulatory peptides associated with neuronal signalling and cellular communication.

Within laboratory environments the peptide is studied for its interaction with intracellular signalling systems and regulatory pathways that influence neuronal activity and molecular communication processes.

Experimental models frequently examine Cortagen in relation to peptide-mediated regulation of cellular signalling pathways and biochemical regulatory systems.

The defined peptide structure allows researchers to investigate regulatory peptide signalling behaviour within controlled laboratory environments.

Historical Background and Scientific Context

Scientific interest in regulatory peptides expanded significantly during the late twentieth century as advances in molecular biology allowed researchers to identify short peptide sequences involved in cellular communication and signalling.

Researchers began studying synthetic analogues of naturally occurring regulatory peptides in order to better understand the mechanisms controlling intracellular signalling and neuronal communication.

During this period several short-chain regulatory peptides were developed as research tools to explore biochemical signalling pathways within neural tissue.

Cortagen emerged as one of the peptides studied in experimental models examining peptide-mediated regulation of neuronal signalling systems.

Mechanistic Focus in Research

Within experimental laboratory environments, Cortagen is often studied in relation to neurobiological signalling pathways and regulatory peptide interaction mechanisms.

Research investigations commonly explore the compound in experimental models examining:

• Neuronal signalling pathway dynamics
• Regulatory peptide signalling mechanisms
• Intracellular molecular communication systems
• Neurobiological regulatory network modelling
• Peptide-mediated cellular signalling
• Comparative regulatory peptide research
• Experimental neurochemical signalling pathways

These experimental models allow scientists to investigate molecular regulatory mechanisms influencing neuronal communication and cellular signalling processes.

Research Applications

In controlled research environments, Cortagen may be utilised in experimental models designed to explore neurobiological signalling pathways and regulatory peptide systems.

Examples of research applications include:

• Neuronal signalling pathway investigation
• Regulatory peptide research
• Intracellular signalling analysis
• Neurochemical regulatory network studies
• Comparative peptide signalling modelling
• Molecular neurobiology research
• Controlled in vitro peptide signalling studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 20.4 mg
Purity greater than 99.8 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.